Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mohamed Teleb

Vascular Neurology Mesa, AZ Medical Doctor

NPI 1750432035 CMS profile 470353

1520 S Dobson Rd Ste 203, Mesa, AZ 85202

Open in the dashboard

General payments

$137,457

630 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$272,012 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Mohamed Teleb of Mesa, AZ is reported in the CMS Open Payments database as having received $137,457 across 630 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $272,012 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,793 107
2024 General $31,321 113
2023 General $21,843 112
2022 General $16,637 98
2021 General $25,865 79
2020 General $6,923 62
2019 General $16,074 59

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mohamed Teleb
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Mohamed Teleb were reported at $18,793. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Mohamed Teleb Vascular Neurology median Middle half National median
2019 $16,074 $263 $102–$1,640 $163
2020 $6,923 $153 $45–$1,000 $114
2021 $25,865 $261 $100–$1,355 $132
2022 $16,637 $242 $87–$1,273 $149
2023 $21,843 $322 $97–$1,266 $160
2024 $31,321 $247 $70–$1,053 $164
2025 $18,793 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $46,719 193 payments
  2. Penumbra, Inc. $42,854 150 payments
  3. Stryker Corporation $24,408 40 payments
  4. Medical Device Business Services, Inc. $6,644 12 payments
  5. Medtronic, Inc. $4,276 40 payments
  6. DePuy Synthes Sales Inc. $3,833 103 payments
  7. Imperative Care, INc $2,084 31 payments
  8. Medtronic Vascular, Inc. $1,761 14 payments
  9. Balt USA, LLC $1,733 9 payments
  10. Terumo Medical Corporation $1,689 9 payments
  11. Other $1,457 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $51,619 21 payments
  2. Consulting Fee $38,525 15 payments
  3. Travel and Lodging $23,313 79 payments
  4. Food and Beverage $22,410 513 payments
  5. Grant $1,500 1 payment
  6. Education $90 1 payment
Products named General payments · program years 2019–2025
  1. Penumbra System $34,881 71 payments
  2. ERIC RETRIEVAL DEVICE $20,800 78 payments
  3. WEB ANEURYSM EMBOLIZATION SYSTEM $15,857 58 payments
  4. TREVO Microcatheterstentriever $15,642 11 payments
  5. SOFIA 6F-131CM STR $7,274 58 payments
  6. Embotrap $5,503 15 payments
  7. Pipeline $3,735 20 payments
  8. TREVO Microcatheterstentriever $3,456 7 payments
  9. Smart Coil $3,215 12 payments
  10. REVOLUTION $3,200 1 payment
  11. Other $28,792 469 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

32

Median for Neurology: 833

Drug cost

$567

Median for Neurology: $202,670

Branded share of claims

100%

Median for Neurology: 25.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 32 $567

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$61,304

Medicare's payments for the services billed

Medicare patients

155

Average age 77

Services billed

493

76 women, 79 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 48%
Arthritis 45%
Chronic kidney disease 39%
Diabetes 38%
Atrial fibrillation 37%
Depression 27%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

630 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record